20
Mylan Laboratories Limited Hyderabad In, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Naproxen, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-008 - Rev 06
This Chemical Type CEP, issued on September 25, 2017, remains in force until May 25, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 731 associated with this CEP further emphasizes